El-Tokhy, Mervat A <br/><br/>
XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Oct 2014 
 - 397-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1179/1607845413Y.0000000144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Amino Acid Substitution<br/>Chi-Square Distribution<br/>Cytogenetic Analysis<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Female<br/>Gene Frequency<br/>Genetic Predisposition to Disease--genetics<br/>Genotype<br/>Heart Diseases--chemically induced<br/>Humans<br/>Induction Chemotherapy--adverse effects<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Monte Carlo Method<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic<br/>Polymorphism, Restriction Fragment Length<br/>Prognosis<br/>Risk Factors<br/>Xeroderma Pigmentosum Group D Protein--genetics<br/>Young Adult